| Financial Year |
March 31 2023 |
| Monetary Funds |
3,228,711,426.90 |
| Held-for-trading Financial Assets |
912,316,584.72 |
| Notes Receivable |
79,832,680.47 |
| Accounts Receivable |
8,516,888,452.29 |
| Advances to Suppliers |
786,378,822.91 |
| Other Receivables |
510,497,952.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,322,432,456.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
282,301,193.76 |
| Total Current Assets |
18,573,673,268.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
414,829,647.24 |
| Long-term Equity Investment |
1,084,362,355.30 |
| Investment Properties |
-- |
| Fixed Assetes |
5,284,061,648.93 |
| Under-construction Projects |
2,974,692,271.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,917,398,070.01 |
| R&D expenses |
829,515,216.17 |
| Goodwill |
973,873,424.81 |
| Long-Term Deferred and Prepaid Expenses |
33,737,818.01 |
| Deferred Income Tax Assets |
68,347,426.60 |
| Other Non-Current Assets |
1,568,604,489.70 |
| Sub-Total of Non-Current Assets |
16,843,573,193.68 |
| Total Assets |
35,417,246,461.81 |
| Short-Term Loans |
5,924,163,459.55 |
| Trading Financial liabilities |
78,219.50 |
| Notes Payable |
852,440,219.09 |
| Accounts Payable |
2,753,918,173.43 |
| Accounts Received In Advance |
309,850,760.79 |
| Employee Compensation Payable |
111,206,155.57 |
| Taxes Payable |
282,936,602.63 |
| Interest Payable |
-- |
| Dividend Payable |
77,277,105.03 |
| Other payables |
1,673,198,103.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,301,588,521.26 |
| Other Current Liabilities |
48,426,943.54 |
| Sub-Total of Current Liabilities |
13,677,433,536.75 |
| Long-term Loans |
1,784,769,918.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
159,054,690.91 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
410,763,502.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,998,589,172.72 |
| Total Liabilities |
16,676,022,709.47 |
| Paid-In Capital(Or Share Stock) |
1,632,715,541.00 |
| Capital Surplus |
5,782,081,854.23 |
| Surplus Reserve |
395,651,769.33 |
| LESS:Treasury Stock |
182,444,876.93 |
| Undistributed Profits |
7,955,182,732.11 |
| Minority Stockholder's Interest |
2,998,837,724.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,742,386,028.25 |
| Owner's Equity（Stockholder's Equity） |
18,741,223,752.34 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
35,417,246,461.81 |
